{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:05:04Z","timestamp":1792731904504,"version":"4.5.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1765,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Chemokines modulate inflammatory responses that are prerequisites for organ fibrosis upon liver injury. Monocyte-derived hepatic macrophages are critical for the development, maintenance, and resolution of hepatic fibrosis. The specific role of monocyte-associated chemokine (C-X3-C motif) receptor 1 (CX3CR1) and its cognate ligand fractalkine [chemokine (C-X3-C motif) ligand 1)] in liver inflammation and fibrosis is currently unknown. We examined 169 patients with chronic liver diseases and 84 healthy controls; we found that CX3CL1 is significantly up-regulated in the circulation upon disease progression, whereas CX3CR1 is down-regulated intrahepatically in patients with advanced liver fibrosis or cirrhosis. To analyze the functional relevance of this pathway, two models of experimental liver fibrosis were applied to wild-type (WT) and CX3CR1-deficient mice. Fractalkine expression was induced upon liver injury in mice, primarily in hepatocytes and hepatic stellate cells. CX3CR1\u2212\/\u2212 animals developed greater hepatic fibrosis than WT animals with carbon tetrachloride\u2013induced and bile duct ligation\u2013induced fibrosis. CX3CR1\u2212\/\u2212 mice displayed significantly increased numbers of monocyte-derived macrophages within the injured liver. Chimeric animals that underwent bone marrow transplantation revealed that CX3CR1 restricts hepatic fibrosis progression and monocyte accumulation through mechanisms exerted by infiltrating immune cells. In the absence of CX3CR1, intrahepatic monocytes develop preferentially into proinflammatory tumor necrosis factor\u2013producing and inducible nitric oxide synthase\u2013producing macrophages. CX3CR1 represents an essential survival signal for hepatic monocyte\u2013derived macrophages by activating antiapoptotic bcl2 expression. Monocytes\/macrophages lacking CX3CR1 undergo increased cell death after liver injury, which then perpetuates inflammation, promotes prolonged inflammatory monocyte infiltration into the liver, and results in enhanced liver fibrosis.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:bold>CX3CR1 limits liver fibrosis<\/jats:bold>\n                                 <jats:bold>\n                                    in vivo\n                                 <\/jats:bold>\n                                 <jats:bold>by controlling the differentiation and survival of intrahepatic monocytes. The opposing regulation of CX3CR1 and fractalkine in patients suggests that pharmacological augmentation of this pathway may represent a possible therapeutic antifibrotic strategy. (Hepatology 2010;52:1769-1782)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.23894","type":"journal-article","created":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T23:30:39Z","timestamp":1281051039000},"page":"1769-1782","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":220,"title":["The Fractalkine Receptor CX3CR1 Protects Against Liver Fibrosis by Controlling Differentiation and Survival of Infiltrating Hepatic Monocytes"],"prefix":"10.1097","volume":"52","author":[{"given":"Karlin Raja","family":"Karlmark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning W.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Roderburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Gassler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann E.","family":"Wasmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20250312","doi-asserted-by":"crossref","first-page":"307318","DOI":"10.2174\/187152809789352230","article-title":"Monocytes and macrophages as cellular targets in liver fibrosis.","volume":"8","author":"Heymann","year":"2009","journal-title":"Inflamm Allergy Drug Targets"},{"key":"R2-27-20250312","doi-asserted-by":"crossref","first-page":"13241332","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGFbeta signaling and hepatic fibrosis.","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"R3-27-20250312","doi-asserted-by":"crossref","first-page":"233242","DOI":"10.1586\/17474124.2.2.233","article-title":"Chemokinedirected immune cell infiltration in acute and chronic liver disease.","volume":"2","author":"Karlmark","year":"2008","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R4-27-20250312","first-page":"3845","article-title":"Pathogenesis of liver fibrosis: modulation of stellate cells by chemokines. in German.","volume":"48","author":"Wasmuth","year":"2010","journal-title":"Z Gastroenterol"},{"key":"R5-27-20250312","doi-asserted-by":"crossref","first-page":"261274","DOI":"10.1002\/hep.22950","article-title":"Hepatic recruitment of the inflammatory Gr1 monocyte subset upon liver injury promotes hepatic fibrosis.","volume":"50","author":"Karlmark","year":"2009","journal-title":"Hepatology"},{"key":"R6-27-20250312","doi-asserted-by":"crossref","first-page":"185197","DOI":"10.1002\/hep.22952","article-title":"CCR2 promotes hepatic fibrosis in mice.","volume":"50","author":"Seki","year":"2009","journal-title":"Hepatology"},{"key":"R7-27-20250312","doi-asserted-by":"crossref","first-page":"17661775","DOI":"10.2353\/ajpath.2009.080632","article-title":"Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice.","volume":"174","author":"Mitchell","year":"2009","journal-title":"Am J Pathol"},{"key":"R8-27-20250312","doi-asserted-by":"crossref","first-page":"640644","DOI":"10.1038\/385640a0","article-title":"A new class of membranebound chemokine with a CX3C motif.","volume":"385","author":"Bazan","year":"1997","journal-title":"Nature"},{"key":"R9-27-20250312","first-page":"694703","article-title":"Transmembrane chemokines: versatile special agents in vascular inflammation.","volume":"97","author":"Ludwig","year":"2007","journal-title":"Thromb Haemost"},{"key":"R10-27-20250312","doi-asserted-by":"crossref","first-page":"41064114","DOI":"10.1128\/MCB.20.11.4106-4114.2000","article-title":"Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion.","volume":"20","author":"Jung","year":"2000","journal-title":"Mol Cell Biol"},{"key":"R11-27-20250312","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/S0168-8278(02)00065-X","article-title":"Upregulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans.","volume":"37","author":"Efsen","year":"2002","journal-title":"J Hepatol"},{"key":"R12-27-20250312","doi-asserted-by":"crossref","first-page":"208215","DOI":"10.1016\/j.jhep.2007.09.008","article-title":"The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection.","volume":"48","author":"Wasmuth","year":"2008","journal-title":"J Hepatol"},{"key":"R13-27-20250312","doi-asserted-by":"crossref","first-page":"506516","DOI":"10.1002\/hep.20582","article-title":"Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.","volume":"41","author":"Isse","year":"2005","journal-title":"Hepatology"},{"key":"R14-27-20250312","doi-asserted-by":"crossref","first-page":"567575","DOI":"10.1002\/hep.23318","article-title":"CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis.","volume":"51","author":"Shimoda","year":"2010","journal-title":"Hepatology"},{"key":"R15-27-20250312","first-page":"15261535","article-title":"CX3CL1fractalkine shedding by human hepatic stellate cells: contribution to chronic inflammation in the liver.","volume":"13","author":"BourdBoittin","year":"2009","journal-title":"J Cell Mol Med"},{"key":"R16-27-20250312","doi-asserted-by":"crossref","first-page":"20302039","DOI":"10.1002\/hep.23591","article-title":"CX3CR1 and VAP1 dependent recruitment of CD16 monocytes across human liver sinusoidal endothelium.","volume":"51","author":"Aspinall","year":"2010","journal-title":"Hepatology"},{"key":"R17-27-20250312","doi-asserted-by":"crossref","first-page":"e11049","DOI":"10.1371\/journal.pone.0011049","article-title":"Functional contribution of elevated circulating and hepatic nonclassical CD14CD16 monocytes to inflammation and human liver fibrosis.","volume":"5","author":"Zimmermann","year":"2010","journal-title":"PLoS One"},{"key":"R18-27-20250312","doi-asserted-by":"crossref","first-page":"10701072","DOI":"10.1002\/hep.23542","article-title":"Dendritic cells in liver fibrosis: conductor of the inflammatory orchestra?","volume":"51","author":"Aloman","year":"2010","journal-title":"Hepatology"},{"key":"R19-27-20250312","doi-asserted-by":"crossref","first-page":"209217","DOI":"10.1161\/CIRCRESAHA.107.160697","article-title":"Protective role of CXC receptor 4CXC ligand 12 unveils the importance of neutrophils in atherosclerosis.","volume":"102","author":"Zernecke","year":"2008","journal-title":"Circ Res"},{"key":"R20-27-20250312","first-page":"824829","article-title":"Role of sinusoidal endothelial cells of the liver in concanavalin Ainduced hepatic injury in mice.","volume":"24","author":"Knolle","year":"1996","journal-title":"Hepatology"},{"key":"R21-27-20250312","doi-asserted-by":"crossref","first-page":"521530","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.","volume":"91","author":"Imai","year":"1997","journal-title":"Cell"},{"key":"R22-27-20250312","doi-asserted-by":"crossref","first-page":"963972","DOI":"10.1182\/blood-2008-07-170787","article-title":"CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival.","volume":"113","author":"Landsman","year":"2009","journal-title":"Blood"},{"key":"R23-27-20250312","doi-asserted-by":"crossref","first-page":"825835","DOI":"10.1093\/cvr\/cvp341","article-title":"Fractalkine has antiapoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling.","volume":"85","author":"White","year":"2010","journal-title":"Cardiovasc Res"},{"key":"R24-27-20250312","doi-asserted-by":"crossref","first-page":"30193027","DOI":"10.4049\/jimmunol.180.5.3019","article-title":"Blood monocyte subsets differentially give rise to CD103 and CD103 pulmonary dendritic cell populations.","volume":"180","author":"Jakubzick","year":"2008","journal-title":"J Immunol"},{"key":"R25-27-20250312","doi-asserted-by":"crossref","first-page":"185194","DOI":"10.1172\/JCI28549","article-title":"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.","volume":"117","author":"Tacke","year":"2007","journal-title":"J Clin Invest"},{"key":"R26-27-20250312","first-page":"18581870","article-title":"CCR1 and CCR5 promote hepatic fibrosis in mice.","volume":"119","author":"Seki","year":"2009","journal-title":"J Clin Invest"},{"key":"R27-27-20250312","doi-asserted-by":"crossref","first-page":"372387","DOI":"10.2353\/ajpath.2006.060043","article-title":"Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemiareperfusion injury.","volume":"169","author":"Furuichi","year":"2006","journal-title":"Am J Pathol"},{"key":"R28-27-20250312","doi-asserted-by":"crossref","first-page":"80758080","DOI":"10.1073\/pnas.090017497","article-title":"Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival.","volume":"97","author":"Meucci","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R29-27-20250312","doi-asserted-by":"crossref","first-page":"917924","DOI":"10.1038\/nn1715","article-title":"Control of microglial neurotoxicity by the fractalkine receptor.","volume":"9","author":"Cardona","year":"2006","journal-title":"Nat Neurosci"},{"key":"R30-27-20250312","doi-asserted-by":"crossref","first-page":"166177","DOI":"10.1053\/gast.2002.30329","article-title":"Fractalkinemediated signals regulate cellsurvival and immunemodulatory responses in intestinal epithelial cells.","volume":"122","author":"Brand","year":"2002","journal-title":"Gastroenterology"},{"key":"R31-27-20250312","doi-asserted-by":"crossref","first-page":"17951804","DOI":"10.1161\/CIRCULATIONAHA.108.806158","article-title":"Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage.","volume":"119","author":"Gautier","year":"2009","journal-title":"Circulation"},{"key":"R32-27-20250312","doi-asserted-by":"crossref","first-page":"13901400","DOI":"10.1002\/hep.23795","article-title":"CX3CL1CX3CR1 interaction prevents carbon tetrachlorideinduced liver inflammation and fibrosis in mice.","volume":"52","author":"Aoyama","year":"2010","journal-title":"Hepatology"},{"key":"R33-27-20250312","doi-asserted-by":"crossref","first-page":"74787487","DOI":"10.4049\/jimmunol.179.11.7478","article-title":"Dosedependent differential regulation of cytokine secretion from macrophages by fractalkine.","volume":"179","author":"Mizutani","year":"2007","journal-title":"J Immunol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.23894","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201011000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T11:03:04Z","timestamp":1741777384000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201011000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.23894","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}